Andrew O. Yam

Nuclear Factor-κB Regulates β-Cell Death

David Liuwantara, Mark Elliot, Mariya W. Smith et al. · Diabetes · 2006 · 112 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

Modification of In Vivo and In Vitro T- and B-Cell-Mediated Immune Responses by the<i>Pseudomonas aeruginosa</i>Quorum-Sensing Molecule<i>N</i>-(3-Oxododecanoyl)-<scp>l</scp>-Homoserine Lactone

Adam Ritchie, Andrew O. Yam, Kara M. Tanabe et al. · Infection and Immunity · 2003 · 104 citations · Full text

Life Sciences, Immunology, Microbiology +17

¹⁷⁷Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing¹⁷⁷Lu-PSMA-I&amp;T Therapy

Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker et al. · Journal of Nuclear Medicine · 2022 · 70 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Evaluation of¹⁷⁷Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective¹⁷⁷Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)

Sarennya Pathmanandavel, Megan Crumbaker, Bao Ho et al. · Journal of Nuclear Medicine · 2022 · 60 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

¹⁷⁷Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial

Sarennya Pathmanandavel, Megan Crumbaker, Andrew O. Yam et al. · Journal of Nuclear Medicine · 2021 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17